Skip to main content
. Author manuscript; available in PMC: 2013 Apr 15.
Published in final edited form as: Prostate Cancer Prostatic Dis. 2012 Nov 13;16(1):28–34. doi: 10.1038/pcan.2012.45

Figure 1. Biochemical-relapse free survival analysis by different clinico-pathological characteristics.

Figure 1

To study biochemical-relapse free survival (BRFS), time was calculated from date of RRP to date of biochemical relapse or last follow up. The figure depicts the Kaplan-Meier survival analysis by: a) Gleason score (log-rank p=0.016), b) dichotomous Gleason score (log-rank p=0.011), c) pathological T stage (log-rank p=0.024), and d) margin status (log-rank p<0.001).